Libsyn Directory

Release Date: 03/17/2025

160: Marcel D’Allende survived Stage 4 Lung Cancer | carboplatin | pemetrexed | durvalumab | immunotherapy

Cancer Interviews

Marcel D'Allende was in outstanding health, an avid hiker in the mountains overlooking her hometown of Cape Town, South Africa. However, in October 2021, she began to experience shortness of breath and extreme fatigue. That led to a diagnosis of Stage IV non-small cell adenocarcinoma, or lung cancer. Determined not to let cancer define her, she underwent a treatment regimen of radiotherapy, then chemotherapy with carboplatin and pemetrexed, and immunotherapy with durvalumab. In September 2022, a PET scan revealed Marcel was cancer-free. It took a little while for...

159: Margo Wickersham survived bladder cancer | cystoscopy | radical cystectomy | plasmacytoid

Cancer Interviews

In November 2019, Margo Wickersham noticed blood in her urine. Three months later, she was diagnosed with two types of bladder cancer. After an aggressive chemotherapy regimen, she underwent a radical cystectomy and a hysterectomy in June 2020, resulting in the removal of her bladder, uterus and ovaries, all this during the quarantine phase of the COVID pandemic. Ever since, Margo has been cancer-free, but she had to get fitted with a stoma bag and had to learn how to manage it. The bag is an annoyance, but she considers it a small price to pay in order to stay...

158: Casey Kang survived acute lymphoblastic leukemia | experimental immunotherapy | doxorubicin | methotrexate

Cancer Interviews

When she began experiencing severe bruising and fatigue and turning pale in late 2013, Casey Kang sought medical attention. This led to a diagnosis of acute lymphoblastic leukemia. She was placed on an aggressive, 18-month chemotherapy regimen, which included doxorubicin and methotrexate. Casey relapsed three times during which she was placed on an experimental immunotherapy. All told, she spent 168 days in a hospital, but Casey achieved survivorship. She is now a coach who helps women diagnosed with cancer through the physical, mental and emotional...

157: genetic testing helped stacy martin survive gastric cancer | prophylactic total gastrectomy

Cancer Interviews

Stacy Martin says genetic testing saved her life. The testing indicated she had the CDH1 mutation. The mutation gave her an 80 percent chance of getting gastric cancer and a 60 percent chance of breast cancer. She opted for a prophylactic total gastrectomy to remove her stomach and addressed the possibility of breast cancer with a bilateral mastectomy. Without a stomach, Stacy has had to change the way she eats, requiring food every two hours, and having to completely chew everything she eats. Despite this live-changing surgery, Stacy is leading a healthy...

156: Jonathan Gegerson survived head and neck cancer | salivary duct carcinoma | taxol | herceptin

Cancer Interviews

In 2019, Jonathan Gegerson sought medical attention went he felt a lump on the right side of his neck. After a couple of scans and a biopsy, he was diagnosed with salivary duct carcinoma, a rare form of head and neck cancer. Jonathan survived, but not before enduring 67 sessions of radiation, 12 cycles of chemotherapy (carboplatin, taxol, herceptin) and seven surgeries. He still undergoes a targeted therapy on a monthly basis, and the surgery has affected his speech and his diet, but Jonathan has resumed an active lifestyle that includes skiing and hiking. Jonathan...

155: Luke Mutter survived cholangiocarcinoma | systemic chemotherapy | oxaliplatin | folfirinox | trastuzumab

Cancer Interviews

It took two chemotherapy regimens, but Luke Mutter survived a rare form of bile duct cancer. A CT scan found a 14cm tumor in his liver. At that time, his care team told him he had cancer, but it could not identify the type of cancer. He was put on a systemic chemotherapy cocktail of folfirinox and oxaplatin, which attempt to kill the tumor. When that didn’t work, Luke learned he was a candidate for a hepatic artery infusion, which included chemo far stronger than his first regimen. Luke has achieved survivorship and is very thankful to be to lead a healthy...

154: Linda Trummer survived mantle cell lymphoma | blastoid variant | doxorubicin | vincristine | cytarabine

Cancer Interviews

It was a stressful journey, but Linda Trummer survived Stage IV mantle cell lymphoma. In 2015, she went to her primary care physician after discovering a lump on her jaw line. That led to a diagnosis of a slow-moving blood cancer, MALtoma. However, further tests revealed a lump under her left arm and the diagnosis was upgraded to Stage IV mantle cell lymphoma, a rare form of blood cancer. She underwent R-Hyper-CVAD, a multi-faceted chemotherapy regimen and just two months later was declared to have No Evidence of Disease. Linda still suffers from the many side...

Cancer Interviews

In 2021, one day away from his fortieth birthday, Ty Cedars felt pain in one of his testicles and noticed it was enlarged. He contacted his physician, asking to be seen. The following day, en route to a birthday celebration, Ty received a call from his doctor, requesting that Ty come right away. The Alexandria, Louisiana-based schoolteacher soon underwent an ultrasound, then was directed to a urologist, who told Ty that he had testicular cancer. He took the news calmly and was told by the doctor that this was a very treatable cancer, but that he would have to go on a...

152: erin bloodworth exercise oncologist | fitness assessment | individualized exercise program | lymphedema | neuropathy

Cancer Interviews

A clinical exercise physiologist by trade, Erin Bloodworth sought a career change and became an exercise oncologist. This enabled her to take her expertise and apply it to helping cancer patients, which she does through Northwestern Medicine Living Well. Erin says whether a patient is going through cancer treatment or is post-treatment, she puts the patient through an individualized exercise program. She assesses the patient's health with tests tied to their ability to grip objects and go from a sitting position to a standing position and...

151: Stewart Greenfield survived stage IV bladder cancer | cisplatin | gemcidibine | novolumab | immunotherapy

Cancer Interviews

For Stewart Greenfield, the third time was the charm. After checking pictures of his bladder in 2016, two doctors told him he didn’t have long to live; a third doctor told him he had Stage IV metastatic bladder cancer, but insisted he needed to be treated. The cancer had burned a hole in his bladder and attacked lymph nodes from his groin to his neck. Treatment included a chemotherapy cocktail of cisplatin and gemcidibine, plus qualifying for an immunotherapy, novolumab. It was a smashing success. Stewart says his urinary function is normal and he is able to...

More Episodes

When Jessica Whorton discovered lumps on her left breast in 2011, she sought medical attention. The doctors she spoke with said breast cancer was not indicated. She walked around with the lumps for another nine months before seeking a second opinion. Tests revealed she had Stage 3A invasive ductal carcinoma. Doctors urged that she get a double mastectomy even though her right breast was still healthy. After chemotherapy and radiation, Jessica achieved survivorship in 2013.

Jessica thought there was something wrong when she detected three lumps on her left breast in 2011. She had them looked at, but doctors said they didn’t feel anything that seemed cancerous. Jessica did nothing for the next nine months, but then decided she needed to be seen by a different care team, led by a plastic surgeon. After tests and a biopsy, he said while her right breast was healthy, there was cancer in her left breast.

As if that diagnosis weren’t enough, her care team urged Jessica to undergo a double mastectomy to minimize the chance of a recurrence in the right breast. The following week she underwent the procedure, and it was successful.

Jessica was told her post-surgery regimen would have to start with what is known as the ‘red devil,’ a highly-potent chemotherapy cocktail. She suffered the usual side effects, including extreme fatigue and hair loss. After the red devil, Jessica was supposed to go on Taxol, but she had an allergic reaction to it and the Taxol was discontinued after two dosages.

Next up was super radiation, requiring 30 visits administered five days a week. Jessica said the Taxol experience made the radiation even tougher, and just when she started feeling better after her weekly two days off, she would have to go in for more radiation.

However, things changed for the better and in 2013, Jessica Wharton was told she had gone into remission. The day she got the news was, she said, “Like winning the lottery.” She has been in remission ever since.

Jessica says to this day she still feels the effects of PTSD and is not able to return to the workforce on a full-time basis, but she is grateful that cancer is in her past.

TOPICS